We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Healthcare Ent. | LSE:HCEG | London | Ordinary Share | GB00B6030H73 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:5974H Healthcare Enterprise Group PLC 14 August 2006 14 August 2006 Healthcare Enterprise Group PLC Contracts and deferred acquisition payment update Healthcare Enterprise Group PLC (Aim: HCEG, "HCEG"), the international healthcare products group, announces that it will not now be required to make payment of #1.3 million as additional consideration for the acquisition of Crest Medical which was announced on 17 November 2004. This payment was conditional on two bespoke supply contracts between HCEG and the Metropolitan Police being extended or renewed on terms acceptable to HCEG. Following a tender process, these contracts have now been awarded to other organisations. In the view of the Board, a combination of these two events should have a broadly neutral impact on the Group's profitability for year ending 28 February 2007. The revenue and contribution loss from these two low margin supply contracts is mitigated by the financial savings as a result of HCEG not having to pay the #1.3m final installment. There will be an improvement in HCEG's working capital following the release of special stock being held for these contracts. The annual revenue of these two contracts was #2.6m. However, they were, in the main, extremely complex and barely profitable outsourcing agreements which provided few synergistic opportunities within HCEG's Warrington operation. There is no impact on the recently announced supply agreements. HCEG continues to make progress following its strategic review and the Board will continue to focus efforts on maximizing shareholder value. Enquiries: College Hill 020 7457 2020 Corinna Dorward This information is provided by RNS The company news service from the London Stock Exchange END CNTGUUMCRUPQGMG
1 Year Healthcare Enterprise Chart |
1 Month Healthcare Enterprise Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions